• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS ANTI-SARS-COV-2; CORONAVIRUS SEROLOGICAL REAGENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS ANTI-SARS-COV-2; CORONAVIRUS SEROLOGICAL REAGENT Back to Search Results
Catalog Number 09203079190
Device Problem False Negative Result (1225)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 06/23/2020
Event Type  malfunction  
Manufacturer Narrative
This event occurred in (b)(6).The sensitivity of the elecsys anti sars cov 2 assay early after infection is unknown.Negative results do not preclude acute sars cov 2 infection.If acute infection is suspected, direct testing for sars cov 2 is necessary.The patient sample was requested for investigation.
 
Event Description
The initial reporter complained of discrepant negative results for 1 patient tested for elecsys anti-sars-cov-2 (anti-sars-cov-2) on a cobas e801 module.On 19-may-2020 the patient had a positive pcr result.On 23-jun-2020 the patient sample was tested multiple times on the e801 module with negative results (0.198 coi).On 24-jun-2020 the patient sample was tested multiple times by the diasorin method with positive results (24.2 au/ml) it is not known if any questionable results were reported outside of the laboratory.The e801 module serial number was (b)(4).
 
Manufacturer Narrative
Section d4, lot number and expiration date were updated.Calibration and qc at the customer site was acceptable.The patient sample was submitted for investigation.The customer's result was reproduced with the elecsys anti-sars-cov-2 assay.Additional measurements determined this sample as positive with a rapid assay (weak igg) from creative diagnostics as well as an independent in-house roche assay detecting other antibodies against sars-cov-2.Given that the patient is regularly exposed to the common cold corona viruses (hku1, 229e, oc43 and nl63), an effective anti-corona-virus immune response might be in place, therefore differing from immune responses of naïve patients.As the determined coi-value for the investigated sample was slightly elevated after 30 days post positive pcr, a follow-up sample would be expected to result as positive.A general reagent issue can be excluded.The investigation did not identify a product problem.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS ANTI-SARS-COV-2
Type of Device
CORONAVIRUS SEROLOGICAL REAGENT
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key10310564
MDR Text Key200839145
Report Number1823260-2020-01768
Device Sequence Number1
Product Code QKO
Combination Product (y/n)N
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 08/12/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/22/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/30/2020
Device Catalogue Number09203079190
Device Lot Number496292
Was Device Available for Evaluation? Yes
Date Manufacturer Received06/24/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age52 YR
-
-